Latigo Biotherapeutics Insider Trades
NASDAQ: LTGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 2 · $5.04M
- Sales
- 0 · $0
- Shares bought / sold
- 280.00K / 0
- Net activity
- Net buying $5.0 million
Latigo Biotherapeutics insider activity
Over the last 12 months, Latigo Biotherapeutics insiders reported 34 transactions on SEC Form 4: 2 open-market purchases and 0 sales. Insiders bought $5.0 million and sold $0 worth of stock, for net insider buying of $5.0 million. The most recent filing shows Sanofi (10% Owner) reporting a transaction in 494,800 shares on Aug 10, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put LTGO's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
LTGO insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 10, 2026 | SEIDENBERG BETH CDirector | Conversion | 2,066,857 | — | Form 4 |
| Aug 10, 2026 | SEIDENBERG BETH CDirector | Conversion | 165,519 | — | Form 4 |
| Aug 10, 2026 | SEIDENBERG BETH CDirector | Conversion | 1,484,401 | — | Form 4 |
| Aug 10, 2026 | SEIDENBERG BETH CDirector | Conversion | 3,464,072 | — | Form 4 |
| Aug 10, 2026 | SEIDENBERG BETH CDirector | Conversion | 1,027,635 | — | Form 4 |
| Aug 10, 2026 | SEIDENBERG BETH CDirector | Conversion | 3,547,842 | — | Form 4 |
| Aug 10, 2026 | SEIDENBERG BETH CDirector | Conversion | 938,979 | — | Form 4 |
| Aug 10, 2026 | Tananbaum James B.Director | Conversion | 296,880 | — | Form 4 |
| Aug 10, 2026 | Tananbaum James B.Director | Conversion | 3,117,664 | — | Form 4 |
| Aug 10, 2026 | Tananbaum James B.Director | Conversion | 195,776 | — | Form 4 |
| Aug 10, 2026 | Tananbaum James B.Director | Buy | 140,000 | $2.52M | Form 4 |
| Aug 10, 2026 | Tananbaum James B.Director | Conversion | 742,201 | — | Form 4 |
| Aug 10, 2026 | Tananbaum James B.Director | Conversion | 1,125,823 | — | Form 4 |
| Aug 10, 2026 | Tananbaum James B.Director | Conversion | 445,320 | — | Form 4 |
| Aug 10, 2026 | Tananbaum James B.Director | Conversion | 3,117,664 | — | Form 4 |
| Aug 10, 2026 | Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Management VI LLC & Foresite Capital Fund VI LP10% Owner | Conversion | 296,880 | — | Form 4 |
| Aug 10, 2026 | Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Management VI LLC & Foresite Capital Fund VI LP10% Owner | Conversion | 3,117,664 | — | Form 4 |
| Aug 10, 2026 | Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Management VI LLC & Foresite Capital Fund VI LP10% Owner | Conversion | 195,776 | — | Form 4 |
| Aug 10, 2026 | Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Management VI LLC & Foresite Capital Fund VI LP10% Owner | Buy | 140,000 | $2.52M | Form 4 |
| Aug 10, 2026 | Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Management VI LLC & Foresite Capital Fund VI LP10% Owner | Conversion | 742,201 | — | Form 4 |
| Aug 10, 2026 | Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Management VI LLC & Foresite Capital Fund VI LP10% Owner | Conversion | 1,125,823 | — | Form 4 |
| Aug 10, 2026 | Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Management VI LLC & Foresite Capital Fund VI LP10% Owner | Conversion | 445,320 | — | Form 4 |
| Aug 10, 2026 | Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Management VI LLC & Foresite Capital Fund VI LP10% Owner | Conversion | 3,117,664 | — | Form 4 |
| Aug 10, 2026 | Westlake BioPartners Fund I, L.P. & Westlake BioPartners GP I, LLC & Westlake BioPartners Fund II, L.P. & Westlake BioPartners GP II, LLC & Westlake BioPartners Opportunity Fund I, L.P. & Westlake BioPartners Opportunity GP I, LLC10% Owner | Conversion | 2,066,857 | — | Form 4 |
| Aug 10, 2026 | Westlake BioPartners Fund I, L.P. & Westlake BioPartners GP I, LLC & Westlake BioPartners Fund II, L.P. & Westlake BioPartners GP II, LLC & Westlake BioPartners Opportunity Fund I, L.P. & Westlake BioPartners Opportunity GP I, LLC10% Owner | Conversion | 165,519 | — | Form 4 |
| Aug 10, 2026 | Westlake BioPartners Fund I, L.P. & Westlake BioPartners GP I, LLC & Westlake BioPartners Fund II, L.P. & Westlake BioPartners GP II, LLC & Westlake BioPartners Opportunity Fund I, L.P. & Westlake BioPartners Opportunity GP I, LLC10% Owner | Conversion | 1,484,401 | — | Form 4 |
| Aug 10, 2026 | Westlake BioPartners Fund I, L.P. & Westlake BioPartners GP I, LLC & Westlake BioPartners Fund II, L.P. & Westlake BioPartners GP II, LLC & Westlake BioPartners Opportunity Fund I, L.P. & Westlake BioPartners Opportunity GP I, LLC10% Owner | Conversion | 3,464,072 | — | Form 4 |
| Aug 10, 2026 | Westlake BioPartners Fund I, L.P. & Westlake BioPartners GP I, LLC & Westlake BioPartners Fund II, L.P. & Westlake BioPartners GP II, LLC & Westlake BioPartners Opportunity Fund I, L.P. & Westlake BioPartners Opportunity GP I, LLC10% Owner | Conversion | 1,027,635 | — | Form 4 |
| Aug 10, 2026 | Westlake BioPartners Fund I, L.P. & Westlake BioPartners GP I, LLC & Westlake BioPartners Fund II, L.P. & Westlake BioPartners GP II, LLC & Westlake BioPartners Opportunity Fund I, L.P. & Westlake BioPartners Opportunity GP I, LLC10% Owner | Conversion | 3,547,842 | — | Form 4 |
| Aug 10, 2026 | Westlake BioPartners Fund I, L.P. & Westlake BioPartners GP I, LLC & Westlake BioPartners Fund II, L.P. & Westlake BioPartners GP II, LLC & Westlake BioPartners Opportunity Fund I, L.P. & Westlake BioPartners Opportunity GP I, LLC10% Owner | Conversion | 938,979 | — | Form 4 |
| Aug 10, 2026 | 5AM Ventures VI, L.P. & 5AM Partners VI, LLC & 5AM Opportunities II, L.P. & 5AM Opportunities II (GP), LLC & PARMAR KUSH & Schwab Andrew J.10% Owner | Conversion | 2,350,419 | — | Form 4 |
| Aug 10, 2026 | 5AM Ventures VI, L.P. & 5AM Partners VI, LLC & 5AM Opportunities II, L.P. & 5AM Opportunities II (GP), LLC & PARMAR KUSH & Schwab Andrew J.10% Owner | Conversion | 4,975,543 | — | Form 4 |
| Aug 10, 2026 | Sanofi10% Owner | Conversion | 177,978 | — | Form 4 |
| Aug 10, 2026 | Sanofi10% Owner | Conversion | 494,800 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4